glp-1 news updates november 2025 supply shortage ISPOR 2025: Exploring reasons for discontinuation GLP-1 Drugs Driving Protein Demand – GLP-1 RA prescription trends: January – GLP-1 Receptor Agonist Market Valued

Cristbal Morales, endocrino del hospital Virgen de la Macarena de Sevilla e investigador prolfico en esta materia, destaca cmo estos frmacos han cambiado la percepcin social sobre la obesidad

The prescriber should still evaluate the diagnosis, available approved alternatives, evidence quality, contraindications, potential interactions, monitoring plan, and whether the proposed benefit justifies uncertainty

But, in his nomination hearings, Oz failed to make any GLP-1 commitments, suggesting he may toe the line with Kennedy on any moves in this area

The problem has never been the molecule

This hormone tells your brain that you are full, which helps reduce your overall appetite and cravings